Literature DB >> 31559261

An Overview of Inflammatory Bowel Disease Unclassified in Children.

Lauren E Thurgate1, Daniel A Lemberg1,2, Andrew S Day1,3, Steven T Leach1.   

Abstract

BACKGROUND: The inflammatory bowel diseases cover a diverse range of conditions generally grouped into Crohn's disease (CD) or ulcerative colitis (UC) based on clinical, laboratory, radiological, endoscopic, and histological criteria. However, inflammatory bowel disease unclassified (IBDU) is used when there are clinical and endoscopic signs of chronic colitis without specific features of UC or CD but features of both. Conjecture exists regarding IBDU, especially in children, as to whether it represents a unique childhood phenotype or whether it reflects the difficulties in assigning an IBD subtype at an early age.
SUMMARY: This review examines the current understanding of pediatric IBDU and assesses the evidence supporting IBDU as a distinctive disease entity on the spectrum of inflammatory bowel disease. KEY MESSAGES: Pediatric-onset IBDU is more common than adult-onset IBDU. Therefore, an understanding of IBDU in this age group assumes more importance. However, there remains a paucity of information and a lack of exclusive longitudinal studies on pediatric IBDU. Subsequently there is significant disparity in the reported prevalence, clinical course, reclassification trends, and treatment responses around pediatric IBDU. Therefore, it remains challenging to chart the natural history of pediatric IBDU and consequently form an accurate understanding of where pediatric IBDU sits on the spectrum of disease.

Entities:  

Keywords:  Crohn's disease; Disease classification; Inflammatory bowel disease; Inflammatory bowel disease unclassified; Ulcerative colitis

Year:  2019        PMID: 31559261      PMCID: PMC6751433          DOI: 10.1159/000501519

Source DB:  PubMed          Journal:  Inflamm Intest Dis        ISSN: 2296-9365


  30 in total

1.  Indeterminate colitis: a significant subgroup of pediatric IBD.

Authors:  Ryan S Carvalho; Vivian Abadom; Harrison P Dilworth; Richard Thompson; Maria Oliva-Hemker; Carmen Cuffari
Journal:  Inflamm Bowel Dis       Date:  2006-04       Impact factor: 5.325

2.  Frequency of indeterminate colitis in children and adults with IBD - a metaanalysis.

Authors:  Freerk Prenzel; Holm H Uhlig
Journal:  J Crohns Colitis       Date:  2009-08-06       Impact factor: 9.071

3.  Inflammatory bowel disease in children: epidemiological analysis of the nationwide IBD registry in Japan.

Authors:  Takashi Ishige; Takeshi Tomomasa; Tohru Takebayashi; Keiko Asakura; Mamoru Watanabe; Tomoko Suzuki; Reiko Miyazawa; Hirokazu Arakawa
Journal:  J Gastroenterol       Date:  2010-03-16       Impact factor: 7.527

4.  Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease.

Authors:  Katalin E Müller; Péter L Lakatos; András Arató; Judit B Kovács; Ágnes Várkonyi; Dániel Szűcs; Erzsébet Szakos; Enikő Sólyom; Márta Kovács; Marianne Polgár; Éva Nemes; Ildikó Guthy; István Tokodi; Gergely Tóth; Ágnes Horváth; András Tárnok; Noémi Csoszánszki; Márta Balogh; Noémi Vass; Piroska Bódi; Antal Dezsőfi; László Gárdos; Eva Micskey; Mária Papp; Áron Cseh; Dolóresz Szabó; Péter Vörös; Gabor Veres
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-11       Impact factor: 2.839

5.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.

Authors:  J Satsangi; M S Silverberg; S Vermeire; J-F Colombel
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

6.  Inflammatory bowel disease unclassified.

Authors:  Ning Zhou; Wei-xing Chen; Shao-hua Chen; Cheng-fu Xu; You-ming Li
Journal:  J Zhejiang Univ Sci B       Date:  2011-04       Impact factor: 3.066

7.  [Application of the Porto criteria for the diagnosis of paediatric inflammatory bowel disease in a paediatric reference centre].

Authors:  J Martín de Carpi; V Vila; V Varea
Journal:  An Pediatr (Barc)       Date:  2011-05-05       Impact factor: 1.500

8.  Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry.

Authors:  Melvin B Heyman; Barbara S Kirschner; Benjamin D Gold; George Ferry; Robert Baldassano; Stanley A Cohen; Harland S Winter; Patricia Fain; Chris King; Terry Smith; Hashem B El-Serag
Journal:  J Pediatr       Date:  2005-01       Impact factor: 4.406

9.  Natural history of paediatric inflammatory bowel diseases over a 5-year follow-up: a retrospective review of data from the register of paediatric inflammatory bowel diseases.

Authors:  Elizabeth A Newby; Nick M Croft; Michael Green; Kamal Hassan; Robert B Heuschkel; Huw Jenkins; David H Casson
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-05       Impact factor: 2.839

Review 10.  Crohn's and colitis in children and adolescents.

Authors:  Andrew S Day; Oren Ledder; Steven T Leach; Daniel A Lemberg
Journal:  World J Gastroenterol       Date:  2012-11-07       Impact factor: 5.742

View more
  6 in total

Review 1.  Serum ANCA as Disease Biomarkers: Clinical Implications Beyond Vasculitis.

Authors:  Marco Folci; Giacomo Ramponi; Virginia Solitano; Enrico Brunetta
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-30       Impact factor: 10.817

2.  The clinical, molecular, and therapeutic features of patients with IL10/IL10R deficiency: a systematic review.

Authors:  Niusha Sharifinejad; Majid Zaki-Dizaji; Roya Sepahvandi; Farimah Fayyaz; Maria Marluce Dos Santos Vilela; Gehad ElGhazali; Hassan Abolhassani; Hans D Ochs; Gholamreza Azizi
Journal:  Clin Exp Immunol       Date:  2022-06-23       Impact factor: 5.732

Review 3.  Therapy Strategies for Children Suffering from Inflammatory Bowel Disease (IBD)-A Narrative Review.

Authors:  Corinne Légeret; Raoul Furlano; Henrik Köhler
Journal:  Children (Basel)       Date:  2022-04-26

4.  Urinary Metabolites Enable Differential Diagnosis and Therapeutic Monitoring of Pediatric Inflammatory Bowel Disease.

Authors:  Mai Yamamoto; Meera Shanmuganathan; Lara Hart; Nikhil Pai; Philip Britz-McKibbin
Journal:  Metabolites       Date:  2021-04-15

5.  Effects of Jian Pi Qing Chang Hua Shi decoction on mucosal injuries in a 2,4,6-trinitrobenzene sulphonic acid-induced inflammatory bowel disease rat model.

Authors:  Huicun Zhang; Na Ta; Hong Shen; Hongbing Wang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

6.  Profiling non-coding RNA levels with clinical classifiers in pediatric Crohn's disease.

Authors:  Ranjit Pelia; Suresh Venkateswaran; Jason D Matthews; Yael Haberman; David J Cutler; Jeffrey S Hyams; Lee A Denson; Subra Kugathasan
Journal:  BMC Med Genomics       Date:  2021-07-29       Impact factor: 3.063

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.